Vitamin D is unusual in the supplement world: it's a supplement people take because they're deficient, not because a company invented a marketing angle.
And deficiency is genuinely common. The NHANES data suggests 40% of US adults have vitamin D below the sufficiency threshold. In northern latitudes and among people with darker skin, deficiency rates are higher.
But that's not the same as "more vitamin D = more health." Here's what the research actually shows.
What vitamin D does
Vitamin D is technically a hormone, not a vitamin. It's produced in the skin from cholesterol when exposed to UVB radiation, then converted to its active form (calcitriol) by the kidneys.
Core functions:
- Calcium and phosphate absorption
- Bone mineralization
- Immune system regulation
- Some role in muscle function
- Emerging research: mood regulation, mitochondrial function
Deficiency causes rickets in kids, osteomalacia and osteoporosis in adults, and correlates with a laundry list of conditions from depression to cardiovascular disease. Correlation, however, is not causation — a critical distinction that most vitamin D marketing ignores.
The 25(OH)D blood test
Serum 25-hydroxyvitamin D is the standard measurement. Thresholds vary by organization:
- <20 ng/mL (50 nmol/L): Deficient — clinically significant
- 20–30 ng/mL: Insufficient
- 30–50 ng/mL: Optimal for most experts
- 50–80 ng/mL: Upper end of "normal"
- >100 ng/mL: Approaching toxicity risk zone
The optimal range is debated. Some argue 40–60 ng/mL is ideal; others say 30 ng/mL is sufficient. The evidence for benefits above 40 ng/mL is much weaker than the evidence for correcting deficiency.
Where the research is strong
Bone health in deficient populations: Very solid. Meta-analyses consistently show vitamin D + calcium reduces fracture risk in older adults with low baseline vitamin D.
Muscle function in the elderly: Multiple RCTs show vitamin D supplementation reduces falls in vitamin D-deficient elderly adults.
Rickets prevention: Absolute lock. This is why milk is fortified.
Where the research is mixed or weak
Cardiovascular disease: Observational studies show correlation between low vitamin D and cardiovascular disease. RCTs (VITAL trial, 25,000+ participants) show vitamin D supplementation does not reduce cardiovascular events.
Cancer: Same story. VITAL and other large RCTs show no significant cancer risk reduction from supplementation, despite observational data suggesting a link.
Depression: Some evidence for benefit in deficient individuals with clinical depression. Effect is modest, and probably specific to correcting deficiency, not adding on top of adequate levels.
Immune function: Modest evidence for reduced respiratory infection risk, particularly in deficient populations. The pandemic-era enthusiasm outran the data — vitamin D helps if you're deficient, but doesn't prevent infections in already-sufficient people.
Testosterone in men: Some correlation studies. RCT evidence is mixed and effect sizes small. Almost certainly a deficiency-correction effect, not a supplementation effect.
Why the pattern keeps appearing
Here's the thing: correcting deficiency has broad benefits, but supplementing beyond sufficiency doesn't.
This matters because supplement marketing loves to conflate the two. "Studies show vitamin D reduces X!" — those studies were typically done on deficient populations. The benefit is bringing deficient people to sufficient. It's not "more is better" indefinitely.
Dosing
The research-based recommendations:
- If deficient (<20 ng/mL): 5,000 IU/day for 8–12 weeks, then retest and adjust
- Maintenance (once sufficient): 1,000–2,000 IU/day
- Above 4,000 IU/day chronically without monitoring: Not recommended (toxicity risk over years)
- Take with fat (fat-soluble vitamin) for absorption
- D3 is preferred over D2 — better absorbed, more effective at raising blood levels
Co-factors that matter:
- Vitamin K2 (menaquinone): Directs calcium to bones vs. arteries. Some evidence for taking together. K2-MK7 form at 100–200mcg.
- Magnesium: Required for vitamin D activation. If low, supplementation is less effective.
The toxicity question
Vitamin D toxicity is rare but real. Chronic dosing above 10,000 IU/day can cause hypercalcemia (dangerously high blood calcium), kidney stones, and cardiovascular damage.
Acute toxicity requires enormous doses. Chronic toxicity requires sustained high supplementation. Most cases in the literature involve dosing errors (e.g., a manufacturer error putting 100× the intended dose in each capsule).
Takeaway: 2,000–4,000 IU/day is safe long-term. Don't casually take 10,000+ IU/day without measurement.
The framework applied
Any vitamin D study, evaluate:
- Baseline vitamin D levels of subjects. Deficient populations respond differently.
- Was the dose sufficient to change blood levels? Some studies use 400 IU — which barely moves the needle.
- Duration. Vitamin D takes months to plateau; short studies miss effects.
- Primary outcome. Blood levels ≠ clinical outcomes. Look for actual endpoints (fractures, falls, disease events).
- RCT vs. observational. Vitamin D has massive observational data and much weaker RCT evidence — a classic sign of confounding.
We automated this at Q-SCI. Any study — paste it, get a quality score.
Bottom line
- Get tested. If below 30 ng/mL, supplement 5,000 IU/day for 8 weeks, retest.
- Once sufficient, 1,000–2,000 IU/day maintenance
- Take with fat, ideally with a meal
- Consider K2-MK7 alongside for cardiovascular consideration
- Don't expect miraculous effects if you're already sufficient
- Sunlight is still the physiological default; 15–30 min of midday sun in summer covers most people
Vitamin D is genuinely one of the few supplements worth considering — but only after confirming you actually need it.
More evidence-based analyses at q-sci.org/blog. Score studies free at q-sci.org.
Top comments (0)